AstraZeneca maker reduces vaccine efficacy by 3 percent after independent group query
An updated company analysis of the coronavirus vaccine developed by AstraZeneca and the University of Oxford showed that the two-shot regimen was robustly effective — 76 percent at preventing symptomatic ...
